Aspen Pharmacre Hl ADR (APNHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 628,711 | 456,789 | 405,399 | 632,879 | 689,773 |
| Receivables | 1,230,971 | 852,141 | 814,817 | 882,026 | 932,676 |
| Inventories | 918,188 | 1,056,997 | 977,439 | 1,032,684 | 1,088,693 |
| Other current assets | 11,556 | 0 | 387,762 | 1,127 | 458,543 |
| TOTAL | $2,789,426 | $2,365,927 | $2,585,417 | $2,548,716 | $3,169,685 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,339,198 | N/A | 1,207,453 | N/A |
| Other Non-Current Assets | 4,233,156 | 5,254,912 | 0 | 5,223,982 | 5,437,032 |
| TOTAL | $4,233,156 | $6,594,110 | $N/A | $6,431,435 | $5,437,032 |
| Total Assets | $7,974,218 | $8,576,084 | $8,016,051 | $8,623,278 | $9,423,988 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 527,467 | 405,849 | N/A | 581,484 | 759,743 |
| Accounts payable and accrued liabilities | 571,765 | 624,100 | 0 | 673,628 | 653,076 |
| Other current liabilities | 190,225 | 134,338 | N/A | 157,638 | 136,235 |
| TOTAL | $1,289,457 | $1,164,288 | $1,546,483 | $1,412,750 | $1,549,054 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,878,428 | 2,319,624 | 2,143,107 | 2,799,767 | 3,670,169 |
| Other Non-Current Liabilities | 402,983 | 460,653 | 0 | 444,291 | 391,790 |
| TOTAL | $2,424,834 | $2,954,221 | $2,143,107 | $3,388,513 | $4,219,863 |
| Total Liabilities | $3,714,291 | $4,118,509 | $4,205,039 | $4,801,262 | $5,768,917 |
| Shareholders' Equity | |||||
| Common Shares | 119,669 | 122,489 | N/A | 134,726 | 131,342 |
| Retained earnings | N/A | 2,956,668 | N/A | 2,907,843 | N/A |
| Other shareholders' equity | 4,140,258 | 1,378,418 | 3,811,012 | 779,448 | 3,523,729 |
| TOTAL | $4,259,927 | $4,457,575 | $3,811,012 | $3,822,017 | $3,655,071 |
| Total Liabilities And Equity | $7,974,218 | $8,576,084 | $8,016,051 | $8,623,279 | $9,423,988 |